BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31748606)

  • 21. Regulation of differentiation by a PHD domain in the NUP98-PHF23 fusion protein.
    Reader JC; Leng Q; Rassool FV; Ning Y
    Leuk Res; 2010 Aug; 34(8):1094-7. PubMed ID: 20219246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.
    Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; García-Lozano JR; Falantes JF; Prats-Martín C; Bernal R; Pérez-Simón JA
    Int J Lab Hematol; 2016 Feb; 38(1):64-71. PubMed ID: 26418229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depletion of cytotoxic T-cells does not protect NUP98-HOXD13 mice from myelodysplastic syndrome but reveals a modest tumor immunosurveillance effect.
    Gough SM; Chung YJ; Aplan PD
    PLoS One; 2012; 7(5):e36876. PubMed ID: 22606303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression profiling and candidate gene resequencing identifies pathways and mutations important for malignant transformation caused by leukemogenic fusion genes.
    Novak RL; Harper DP; Caudell D; Slape C; Beachy SH; Aplan PD
    Exp Hematol; 2012 Dec; 40(12):1016-27. PubMed ID: 22885519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A unique mutator phenotype reveals complementary oncogenic lesions leading to acute leukemia.
    Yin M; Baslan T; Walker RL; Zhu YJ; Freeland A; Matsukawa T; Sridharan S; Nussenzweig A; Pruitt SC; Lowe SW; Meltzer PS; Aplan PD
    JCI Insight; 2019 Dec; 4(23):. PubMed ID: 31622281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Flt3 receptor tyrosine kinase collaborates with NUP98-HOX fusions in acute myeloid leukemia.
    Palmqvist L; Argiropoulos B; Pineault N; Abramovich C; Sly LM; Krystal G; Wan A; Humphries RK
    Blood; 2006 Aug; 108(3):1030-6. PubMed ID: 16861351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of p53 accelerates the complications of myelodysplastic syndrome in a NUP98-HOXD13-driven mouse model.
    Xu H; Menendez S; Schlegelberger B; Bae N; Aplan PD; Göhring G; Deblasio TR; Nimer SD
    Blood; 2012 Oct; 120(15):3089-97. PubMed ID: 22927245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HoxA9 binds and represses the Cebpa +8 kb enhancer.
    Peng L; Guo H; Ma P; Sun Y; Dennison L; Aplan PD; Hess JL; Friedman AD
    PLoS One; 2019; 14(5):e0217604. PubMed ID: 31120998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern.
    Hollink IH; van den Heuvel-Eibrink MM; Arentsen-Peters ST; Pratcorona M; Abbas S; Kuipers JE; van Galen JF; Beverloo HB; Sonneveld E; Kaspers GJ; Trka J; Baruchel A; Zimmermann M; Creutzig U; Reinhardt D; Pieters R; Valk PJ; Zwaan CM
    Blood; 2011 Sep; 118(13):3645-56. PubMed ID: 21813447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FLT3ITD drives context-specific changes in cell identity and variable interferon dependence during AML initiation.
    Li Y; Yang W; Patel RM; Casey EB; Denby E; Mendoza-Castrejon J; Rodriguez-Lopez P; Magee JA
    Blood; 2023 Mar; 141(12):1442-1456. PubMed ID: 36395068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of Leukemia-Associated Nup98 Fusion Proteins Generates an Aberrant Nuclear Envelope Phenotype.
    Fahrenkrog B; Martinelli V; Nilles N; Fruhmann G; Chatel G; Juge S; Sauder U; Di Giacomo D; Mecucci C; Schwaller J
    PLoS One; 2016; 11(3):e0152321. PubMed ID: 27031510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
    Calvo KR; Sykes DB; Pasillas MP; Kamps MP
    Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A NUP98-HOXD13 leukemic fusion gene leads to impaired class switch recombination and antibody production.
    Puthiyaveetil AG; Heid B; Reilly CM; HogenEsch H; Caudell DL
    Exp Hematol; 2012 Aug; 40(8):622-33. PubMed ID: 22613470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NUP98-HOXD13 gene fusion in therapy-related acute myelogenous leukemia.
    Raza-Egilmez SZ; Jani-Sait SN; Grossi M; Higgins MJ; Shows TB; Aplan PD
    Cancer Res; 1998 Oct; 58(19):4269-73. PubMed ID: 9766650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NUP98-HOXA9-transgenic zebrafish develop a myeloproliferative neoplasm and provide new insight into mechanisms of myeloid leukaemogenesis.
    Forrester AM; Grabher C; McBride ER; Boyd ER; Vigerstad MH; Edgar A; Kai FB; Da'as SI; Payne E; Look AT; Berman JN
    Br J Haematol; 2011 Oct; 155(2):167-81. PubMed ID: 21810091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transformation of human CD34+ hematopoietic progenitor cells with DEK-NUP214 induces AML in an immunocompromised mouse model.
    Qin H; Malek S; Cowell JK; Ren M
    Oncogene; 2016 Oct; 35(43):5686-5691. PubMed ID: 27065320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of Toll-like receptor 2 results in accelerated leukemogenesis in the
    Monlish DA; Bhatt ST; Duncavage EJ; Greenberg ZJ; Keller JL; Romine MP; Yang W; Aplan PD; Walter MJ; Schuettpelz LG
    Blood; 2018 Mar; 131(9):1032-1035. PubMed ID: 29358180
    [No Abstract]   [Full Text] [Related]  

  • 38. RNA export factor RAE1 contributes to NUP98-HOXA9-mediated leukemogenesis.
    Funasaka T; Nakano H; Wu Y; Hashizume C; Gu L; Nakamura T; Wang W; Zhou P; Moore MA; Sato H; Wong RW
    Cell Cycle; 2011 May; 10(9):1456-67. PubMed ID: 21467841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PUMA promotes apoptosis of hematopoietic progenitors driving leukemic progression in a mouse model of myelodysplasia.
    Guirguis AA; Slape CI; Failla LM; Saw J; Tremblay CS; Powell DR; Rossello F; Wei A; Strasser A; Curtis DJ
    Cell Death Differ; 2016 Jun; 23(6):1049-59. PubMed ID: 26742432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogenous fusion transcripts involving the NUP98 gene and HOXD13 gene activation in a case of acute myeloid leukemia with the t(2;11)(q31;p15) translocation.
    Arai Y; Kyo T; Miwa H; Arai K; Kamada N; Kita K; Ohki M
    Leukemia; 2000 Sep; 14(9):1621-9. PubMed ID: 10995009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.